← Leaderboards
Craig Erickson
Cincinnati Childrens Hosp Med Ctr
$7,667,046
Attributed
$11,481,950
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,161,358 · 9
CDC$4,399,986 · 2
By mechanism
U54$12,039,440 · 5
U01$4,399,986 · 2
P50$2,825,444 · 3
R01$2,296,474 · 1
Top collaborators
- Elizabeth Mara Berry-Kravis5 shared
- Carlos Portera-Cailliau5 shared
- Nicole Renee Tartaglia5 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Kenneth J Campbell$13,429,793
- Brian Gebelein$7,650,132
Others in their field
Top investigators on “Fragile X Syndrome”
- Kimberly M Huber · University Of Texas Sw Med Ctr/Dallas$23,525,029
- Randi J Hagerman · University Of Colorado Denver$22,858,944
- Leonard J Abbeduto · University Of Wisconsin Madison$20,725,077
- Allan L Reiss · Stanford University$19,418,863
- Stephen T. Warren · Emory University$19,071,509
- Paul J Hagerman · University Of Colorado Denver$17,736,077
Research focus
Fragile X SyndromeBrainNeurophysiologyCollaborationsHeterogeneityLinkTranslational MedicineBiological MarkersPharmaceutical PreparationsPre-ClinicalElectroencephalographyClinical ResearchEnsureProgramsNeuronsBehaviorClinical TrialsBench To BedsideMouse ModelElectrophysiology (Science)BehavioralFmr1Knockout MiceDrug Development
Grant awards (34)
Mechanistic and translational medicine studies of brain neurophysiology and phenotypic heterogeneity in fragile X syndrome$1,940,677
P50 · FY2025 · HD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2025 · DD
Neurophysiological and Developmental Mechanisms Underlying Phenotypic Heterogeneity in Boy and Girls with FXS$468,154
P50 · FY2025 · HD · contact PI
Mechanistic and translational medicine studies of brain neurophysiology and phenotypic heterogeneity in fragile X syndrome$416,613
P50 · FY2025 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$1,600,000
U54 · FY2024 · HD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2024 · DD
Circuit Disruptions Underlying Atypical Sensory Processing in Fragile X Syndrome$435,463
R01 · FY2024 · NS
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$408,997
U54 · FY2024 · HD · contact PI
Network Mechanisms, Biomarkers and Pharmacology of Fragile X Syndrome in Humans$367,423
U54 · FY2024 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$84,059
U54 · FY2024 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$1,600,000
U54 · FY2023 · HD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2023 · DD
Circuit Disruptions Underlying Atypical Sensory Processing in Fragile X Syndrome$459,546
R01 · FY2023 · NS
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$400,253
U54 · FY2023 · HD · contact PI
Network Mechanisms, Biomarkers and Pharmacology of Fragile X Syndrome in Humans$368,797
U54 · FY2023 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$54,658
U54 · FY2023 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$1,600,000
U54 · FY2022 · HD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2022 · DD
Circuit Disruptions Underlying Atypical Sensory Processing in Fragile X Syndrome$462,765
R01 · FY2022 · NS
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$393,045
U54 · FY2022 · HD · contact PI
Network Mechanisms, Biomarkers and Pharmacology of Fragile X Syndrome in Humans$372,513
U54 · FY2022 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$1,600,000
U54 · FY2021 · HD · contact PI
Characterizing the Natural History of Fragile X Syndrome to Inform the Development of Intervention,Outcome Measures$800,000
U01 · FY2021 · DD
Circuit Disruptions Underlying Atypical Sensory Processing in Fragile X Syndrome$462,442
R01 · FY2021 · NS
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$388,144
U54 · FY2021 · HD · contact PI
Network Mechanisms, Biomarkers and Pharmacology of Fragile X Syndrome in Humans$376,445
U54 · FY2021 · HD · contact PI
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$1,600,000
U54 · FY2020 · HD · contact PI
Circuit Disruptions Underlying Atypical Sensory Processing in Fragile X Syndrome$476,258
R01 · FY2020 · NS
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome$427,089
U54 · FY2020 · HD · contact PI
Network Mechanisms, Biomarkers and Pharmacology of Fragile X Syndrome in Humans$398,017
U54 · FY2020 · HD · contact PI
Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome (FXS) to Improve Services and Outcomes-Component C$99,998
U01 · FY2019 · DD · contact PI
Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome (FXS) to Improve Services and Outcomes-Component C$99,992
U01 · FY2018 · DD · contact PI
Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome (FXS) to Improve Services and Outcomes-Component C$99,998
U01 · FY2017 · DD · contact PI
Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome (FXS) to Improve Services and Outcomes-Component C$99,998
U01 · FY2016 · DD · contact PI